If you ask any of our staff they will tell you we are accountable to the patients and families in the communities we serve. However, we do have a dedicated group of stakeholders that give us guidance and make sure things run smoothly.
Board of Directors
Christopher Dyrda – Chair of the Board
Having spent his early years in rural Manitoba, Chris graduated from the University of Manitoba with a Bachelors of Commerce degree (1980) and subsequently from Queen’s University in Kingston (1981) with an MBA in Finance. He went on to enjoy a career spanning almost four decades with the TD Bank Financial Group and as a member of the Senior Management Team was, in his last several roles, responsible for the Business Banking operations in the four western Provinces, the three northern Territories, Ontario District, and Quebec. He earned the ICD.D designation in 2009. Chris has been actively involved in charitable work his entire adult life and is currently is the Chair of the CHEO Research Institute board, a Member of the Investment Committee of the CHEO Foundation, a member of the joint Governance Committee between CHEO Research Institute and CHEO, a member of the Investment Committee at Carleton University and a member of the Finance Committee at the Ottawa Hunt and Golf Club. Additionally, Chris is a twenty year board member of First Nations Bank of Canada, a chartered bank with offices across the country with a major focus in the far north, that caters to the needs of Indigenous peoples, First Nations, and various Indigenous enterprises. Chris and his wife Karen split their time between their home in Ottawa and their lake home outside of Perth, Ontario. They have three adult sons each with wonderful partners.
Lynn van der Linde – Vice Chair & Secretary
Executive Consultant, Marketing and Organizational Strategy
Lynn van der Linde is an independent consultant helping corporations, governments and non-profit organizations build effective strategies and high performing teams. She brings more than twenty years of experience in both private and public sectors, having held various executive positions, most recently with IBM and Canadian Blood Services. Lynn has also held various executive Board of Director positions with Canadian charities, namely Fertile Future – an organization that helps young cancer patients understand their fertility options before undergoing cancer treatments that may render them infertile; as well as The IBD Foundation of Canada – where she helped educate and empower youth and adults afflicted with Inflammatory Bowel Disease. Lynn is also an accredited Sommelier and provides wine reviews on behalf of Natalie MacLean. Her most important job though is being the proud mother of two teenage boys. Her oldest son, Max was diagnosed with Ulcerative Colitis in July 2012 where she witnessed first-hand the physical, mental and emotional challenges that come with this disease. This understanding fuels her need to help children affected by IBD – and their parents – and ultimately find better treatments that will only come about through continued investment in research. She believes whole-heartedly in the mission of the CHEO Research Institute and is honoured to contribute to this important cause.
Martin Zablocki – Treasurer
Partner at Gowling WLG
Martin Zablocki is a partner in Gowling WLG’s Ottawa office, practising in the Corporate Group. His practice focuses on assisting Canadian companies to generate sales to foreign governments and helping foreign governments acquire goods and services from Canada. Martin has significant experience working with companies in the infrastructure, aerospace and defence sectors. He also has a notable track record of work with business leaders in Latin America, the Caribbean, Africa, the Middle East and Southeast Asia. Prior to joining Gowling WLG, Martin was the President and CEO of Canadian Commercial Corporation (CCC). CCC is a Canadian Crown corporation focused on international trade, facilitating approximately $2B in exports to foreign governments on an annual basis. Mr. Zablocki held various other senior-level executive positions within CCC, including President and Chief Executive Officer (CEO) wherein Mr. Zablocki provided strategic advice and operational leadership on all aspects of CCC’s business with particular focus on developing and executing strategies to generate business and sales in key markets. In addition, Mr. Zablocki has held the positions of Vice-President – Risk and Finance, and Chief Financial Officer, as well as Vice-President – Strategy and Organizational Development at CCC. Before joining CCC, Mr. Zablocki garnered 17 years of management experience with the Government of Canada, leading regional and national operations within the Canada Revenue Agency, Fisheries and Oceans Canada, and Industry Canada. Mr. Zablocki holds two professional designations, Chartered Business Valuator and Certified Management Accountant, and has served on a variety of volunteer boards and committees
Physician, Blood and Marrow Transplant Program, The Ottawa Hospital Scientist, Centre for Innovative Cancer Research, OHRI; Associate Professor, Department of Medicine, University of Ottawa
Harold Atkins MD is a physician of the Ottawa Hospital Blood and Marrow Transplant Program, an Associate Professor of Medicine at the University of Ottawa, a scientist in the Center for Innovative Cancer Research and the medical director of the Regenerative Medicine Program at the Ottawa Hospital Research Institute. He received his Bachelor of Medical Science degree and Medical Degree from the University of Ottawa followed by a rotating internship year at the Victoria General Hospital in Victoria BC. Specialty training in Internal Medicine was done at the University of Ottawa. Clinical and research fellowships in Hematology, Stem Cell Transplantation and Experimental Hematology followed at the University of Washington and at the Ontario Cancer Institute. He specializes in hematopoietic stem cell transplantation and has spearheaded the use of stem cell transplantation for immune repair to treat patients with severe autoimmune diseases of the nervous system focusing on Multiple Sclerosis. This work was published in the Lancet in 2016. He is running a clinical trial exploring the role of hematopoietic stem cell transplantation in preventing organ transplant rejection. His laboratory research includes a longstanding and fruitful collaboration with Dr. John Bell developing oncolytic viruses particularly for the treatment of hematological cancers as personalized cancer cell vaccines. He was awarded the OHRI’s Dr. Michel Chretien Researcher of the Year in 2016 and the Till and McCulloch Award from the Stem Cell Network in 2017.
Vice-President, Research, University of Ottawa
Sylvain Charbonneau was appointed Interim Vice-President, Research, at the University of Ottawa for a term starting July 1, 2017. He previously held the position of Associate Vice-President, Research at the University. Mr. Charbonneau received a B.Sc. and M.Sc. in Physics from the University of Ottawa and a Ph.D. in Photonics – Semiconductor Physics from Simon Fraser University, B.C. He joined the Institute for Microstructural Sciences at the National Research Council (NRC) in 1988. At the NRC, he led a number of research and development initiatives, including the Canadian Photonics Fabrication Centre and the Printable Electronics flagship program. In late 2000, he co-founded Optenia Inc., an NRC spinoff in the communications technology sector. Mr. Charbonneau has published over 180 papers and has 17 patents and licences in the fields of photonics, nanotechnology and ICT.
General Counsel and Chief Privacy Officer, CHEO
Watson Gale is CHEO’s General Counsel and Chief Privacy Officer as well as interim Vice-President, People, Strategy and Performance. Watson brings over 30 years of experience in law and executive management to his role together with an extensive background in governance. Watson has a business background and a long history of working with not-for-profit and charitable organizations, including being on the board of directors of several key organizations in Ottawa. In addition to practicing law in Ontario, Watson was called to the bar in both Nunavut and the Northwest Territories and has a strong interest in Canada’s amazing northern regions.
Mr. Parm Gill is a serial entrepreneur with a myriad of start-up experience having launched several technology businesses over his career. As Managing Partner of the Gill Group, he acts as a strategic advisor, mentor, investor, and connector for start-up companies. He brings with him the experience and expertise of guiding the growth and development of numerous startup companies, with a focus on strategic planning, business development, fundraising, and intellectual property development and commercialization. His passion for entrepreneurship is equally matched by his passion for giving back to the community through active involvement with a number of charitable and non-profit organizations. You can find out more about him at LinkedIn.com/in/ParmGill, where he can also be contacted, and he can be found on Twitter @ParmSGill
Adjunct Professor of Medicine, University of Ottawa, Senior Scientist, University for Health Sciences, Medical Informatics and Technology in Hall, Tirol Austria
Don Husereau is a Senior Associate with the Institute of Health Economics. He is also an Adjunct Professor of Medicine at The University of Ottawa and Senior Scientist at the University for Health Sciences, Medical Informatics and Technology in Hall in Tirol, Austria. He is a former Director and Senior Advisor with the Canadian Agency for Drugs and Technologies in Health (CADTH). Don’s current research focuses on the value of health system innovation and the use of evidence and economics to inform health policy based on sound principles of social justice, epistemology, and judgment and decision-making. This includes work on science policy and mechanisms to value and manage innovation that benefits innovators, public policy makers/administrators and academics/researchers. He is currently Chair on an International Task Force that has developed consolidated health economic evaluation reporting standards (CHEERS) that is now endorsed by leading biomedical and health policy journals. Don formerly served on the Board of Directors for the International Society of Pharmacoeconomics and Outcomes Research (ISPOR) and is currently an Editorial Advisor for their biomedical journal, Value in Health. He is also an Editorial advisor for the general interest journal BMC Medicine and serves on both the pan-Canadian Oncology Drug Review (pCODR) Expert Review Committee (pERC) and Ontario Committee to Evaluate Drugs. Don received both his BSc in Pharmacy (1993) and his MSc (2000) from the University of Alberta’s Faculty of Pharmacy and Pharmaceutical Sciences.
Nicole Jauvin retired in October 2011 after a 32 year career in the federal government. Since 2000, she was Deputy Minister in a number of other government departments, including the Canadian Northern Economic Development Agency, the Canada Public Service Agency, Social Development Canada and Solicitor General of Canada. A lawyer by training, Ms. Jauvin holds a Licence in Civil Law and a Diploma of graduate studies in Law and was a member of the Quebec Bar throughout her career. She also holds a B.A. in Communications and a Diploma in International Cooperation from the University of Ottawa. She is a Director on a number of Boards, and also enjoys volunteering at The Ottawa Mission, a shelter for homeless people.
President and CEO, Children’s Hospital of Eastern Ontario Foundation
Kevin Keohane is the President and CEO of the Children’s Hospital of Eastern Ontario Foundation. Kevin spent 20 years with the Ottawa Citizen prior to joining the CHEO Foundation as Vice President, Development & Corporate Relations in 2001. In 2011, he was promoted to Chief Operating Officer and was subsequently appointed as President and CEO at the end of 2012. Kevin is also a member of the Canadian Children’s Hospital Foundation Executives (CCHFE) and the CHEO Foundation’s lead representative with Children’s Miracle Network (CMN).
President and CEO, Stratford Managers Corporation
Jim Roche is the President and CEO of Stratford Managers Corporation. He founded the company to positively impact society by helping organizations and their leaders achieve their goals and reach their full potential. Jim’s drive to positively impact society has been a guiding principle throughout his extensive career, leading to impressive accomplishments in privately owned and public companies as well as not-for-profits. As a seasoned executive and corporate director with over 30 years of experience, Jim is a strong advocate for small- and medium-sized companies and an active angel investor. He provides C-level advice on governance, strategy and operational matters, and serves in interim CEO roles. Prior to starting Stratford, Jim began his career as a founding member of Newbridge Networks where he helped grow the company to over $1B in revenue. Jim then co-founded Tundra Semiconductor and during his tenure as President and CEO, the company achieved double-digit average annual revenue and profit growth. Over his career, Jim has sat on over forty boards and committees. He is currently a corporate director on the boards of Ballard Power Systems, Aonix and ThinkRF. As a community builder, Jim also sits on the boards of CHEO and Invest Ottawa, and champions innovation on the boards of Ocean Networks Canada, NRC-IRAP and the Innovation Centre at Bayview Yards. Previous board assignments include Wi-LAN, DNA Genotek, Youth Services Bureau and Queensway Carleton Hospital.
Chief of Staff, CHEO
Dr. Lindy Samson is the Chief of Staff and Chief Medical Officer at CHEO-OCTC. Appointed in April 2016, she is responsible for organizing the activities of the medical staff and for ensuring the quality of clinical care and patient safety. In addition, she is a staff physician in the Division of Infectious Diseases, she holds an academic appointment as Associate Professor in the Department of Paediatrics at the University of Ottawa’s Faculty of Medicine and is a Clinical investigator at the CHEO Research Institute. Her academic and research work is focused on pediatric HIV, the impact of social on the health of children and youth and teaching/evaluating the Health Advocate and Leadership Roles across the continuum of learners. She recently co-chaired an interdisciplinary initiative regarding the future health needs of children and youth in our region.
CO-CEO, Cassidy Bay Group Inc.
Caroline Somers has over 30 years of experience in the high tech industry. She currently is Co-CEO of Cassidy Bay Group, which assists companies to be more effective organizations by building powerful teams and through coaching executives to be successful managers and leaders. She has a wealth of business and operational experience including co-founding a successful startup and angel investing in more than 2 dozen companies. Ms. Somers has served on a number of boards in the community including on the board of Granite Networks (acquired in 2013), Chairman of the board of the Capital Angel Networks, Chairman of DNA Genotek (acquired in 2011), board of Ontario Centres of Excellence, Parteq Innovations, on the advisory board of Amika Mobile, and ICT Advisory board for Department of Foreign Affairs and International trade. She has completed the Directors educations program at the Institute of Corporate Directors. She is very active in the community and on a number of not for profit boards including being a founding board member for a local organization encouraging networking for business women and is currently on Children’s Hospital of Eastern Ontario Research Institute, Chair of Digital Opportunity Trust and on the Innovation council for Joule, a CMA company.
Dean, Faculty of Health Sciences, University of Ottawa
Lucie Thibault, PhD, is professor and dean of the Faculty of Health Sciences at the University of Ottawa in Ontario, Canada. She has worked at Brock University, at The University of British Columbia, and has been a visiting scholar at the Eberhard Karls Universität Tübingen and at the RheinAhr Campus of Koblenz University of Applied Sciences. In 30 years of teaching, Lucie has taught organizational theory, ethics in sport, globalization of sport, governance and policy, and social issues in sport. Lucie serves on the editorial board of the International Journal of Sport Policy and Politics as well as the European Sport Management Quarterly. She has previously held the role of editor of the Journal of Sport Management. She is a member of the North American Society for Sport Management (NASSM) and was named a NASSM research fellow in 2001. In 2008, Lucie was awarded the Earle F. Zeigler Award from NASSM for her scholarly and leadership contributions to the field. Her research interests lie in the formation, management, and evaluation of cross-sectoral partnerships in sport organizations. She also investigates the role of the Canadian government in sport excellence and sport participation and government involvement in developing sport policy. She has been an invited speaker featuring her research in many conferences around the world. Her research has appeared in numerous scholarly journals such as the Journal of Sport Management, International Review for the Sociology of Sport, Journal of Sport and Social Issues, Human Relations, Leisure Studies, European Sport Management Quarterly, International Journal for Sport Policy and Politics, and Nonprofit and Voluntary Sector Quarterly. She is co-editor of Contemporary Sport Management (2018, Human Kinetics) and Sport Policy in Canada (2013, University of Ottawa Press).
Professor and Chair, Department of Obstetrics and Gynecology, The Ottawa Hospital
Dr. Mark Walker earned his Medical Degree from Queen’s University, Kingston, Ontario (1993). His Residency Training in OB/GYN was completed at the University of Ottawa, Ontario (1998); followed by this Fellowship in Maternal-Fetal Medicine at the University of Toronto. In 2003, Dr. Walker earned a Master of Science in Epidemiology from the University of Toronto. He recently graduated from Harvard University with a Masters in Health Care Management. Dr. Mark Walker is a high risk Obstetrician and Clinical Epidemiologist at the University of Ottawa. He has published over 250 per reviewed articles and has made a significant impact in our understanding of folic acid in pregnancy, and thrombophilia in pregnancy. Dr. Walker is highly involved in public policy at the provincial and national levels advocating for women and children’s health. Since joining TOH in 2000, Dr. Walker has held several positions including Fellowship Director for Maternal Fetal Medicine and working closely with the Department of Medicine for the promotion of medical disorders awareness in prenatal care. Dr. Walker’s leadership roles include Chief and Chair of the Department of Obstetrics, Gynecology and Newborn Care at The Ottawa Hospital and University of Ottawa, the scientific Director and co-director of BORN (Better Outcomes Registry and Network), and the Medical Lead for Obstetrics and Gynecology for the Champlain Maternal Newborn Regional Program. He held a Tier 1 Chair from the University of Ottawa in Perinatal Research. He is co-founder of the OMNI Research Group (Obstetrics & Maternal Newborn Investigations) at The Ottawa Hospital.
Research Strategy and Management Team
Chief Executive Officer and Scientific Director
Dr. Jason Berman is the CEO and Scientific Director of the CHEO Research Institute and Vice President Research at CHEO. He is also a Full Professor in the Department of Pediatrics at the University of Ottawa. Previously he served as Associate Chair, Research, Department of Pediatrics, and Professor of Pediatrics, Microbiology & Immunology and Pathology at Dalhousie University and interim Vice President Research, Innovation and Knowledge Translation for the IWK Health Centre in Halifax, Nova Scotia. He has overseen the pediatric leukemia program for the Maritimes since 2005 and chairs an international clinical trial for children with Down syndrome and myeloid leukemia. He is internationally recognized for pioneering research using zebrafish to study childhood cancers and rare inherited diseases. His laboratory has served as the Atlantic node of the Centre for Drug Research and Development and a national hub for zebrafish modeling of orphan diseases. He has been co-chair of the C17 Childhood Cancer Network Developmental Therapeutics Committee and Director of the Clinician Investigator Program and Medical Research Graduate Program at Dalhousie. He is president of the Canadian Society for Clinical Investigation, vice president of the Canadian Hematology Society and a founding member of the Canadian Rare Disease Models and Mechanisms Network.
Chief Operating Officer
Rhonda Correll has been the Chief Operating Officer at the CHEO Research Institute since 2008. Prior to this, she was the founding Director of Operations for the CHEO Research Institute Clinical Research Unit (CRU). Her background in Nursing and Project Management of large multi-site clinical trials has helped CHEO Research earn an internationally respected reputation. In her role as Chief Operating Officer, Rhonda oversees all areas of the Office of Research Services. Additionally, she is responsible for the management of space allocation, risk management, research appointments and coordination of the conflict of interest program. She is also responsible for supporting the Governance and Nomination Committee of the CHEO Research Institute Board of Directors. Key to her role is the planning and execution of the CHEO Research Strategic Plan.
Chris St. Germain
Chief Financial Officer, CHEO Research Institute
Chris is the Chief Financial Officer of the CHEO Research Institute. He is a Chartered Professional Accountant (Chartered Accountant) with more than 30 years of work experience. For over twelve years, Chris has provided leadership of the organization with the assistance of the Finance Officers and is responsible for the financial operations including budgeting, monthly financial reporting, year-end financials, and reporting to the Board of Directors. In addition to the financial operations, he assists researchers with potential commercialization opportunities. Chris began his career at Deloitte where he came a Trustee in Bankruptcy and assisted companies’ turnaround from financial distress. Following his work from Deloitte, he has worked with many different organizations and industries on a part-time basis as a Chief Financial Officer. These organizations include not-for-profit entities, private enterprises, publicly traded companies, and high net worth individuals.
Director of Human Resources
Judy is a seasoned professional with 20+ years of progressive experience in the delivery of innovative HR services, strategies and tools. Previous to joining the CHEO Research Team about 10 years ago she worked in the high tech world holding HR leadership roles with Mitel and BreconRidge as well as doing some HR consulting. She has extensive knowledge and demonstrated skills in multiple Human Resource disciplines, including Benefits, Compensation, Policy, Pension, and Payroll management, as well as managing Training & Development, HR Budgets and HRIS systems, combined with strong HR Operational strategic support. She has exceptional aptitude in research, analysis and implementation, while combining strong relationship building, customer service, organizational and communication skills.
Manager, Health and Safety
Lisa Carter has over 25 years’ experience in Health and Safety, Disability Management, Training and Development and Change Management. Currently Lisa is responsible for the development of CHEO RI best practice standards for effective occupational health and safety management systems and auditing, accident prevent, hazard analysis, risk management & mitigation. Lisa is committed to staying ahead of emerging needs, knowledge and trends, developing forward-thinking safety solutions ensuring the workplace is in compliance with all applicable federal and provincial regulations. Lisa always takes a collaborative management approach in the development and implementation of safety programs such as biosafety, biosecurity, hazardous material management, industrial hygiene, radiation, ergonomics and emergency preparedness. Lisa began her career as an Employment Equity Consultant and Program Director establishing training, development and recruitment programs for Indigenous Women. Lisa’s diverse skillset was further developed in the 20 years working for the Workplace Safety and Insurance Board where she was responsible for the design and implementation province wide safety audits for the Health Care Sector and the development mitigation strategies for large multisite Corporations.
Manager, Grants and Pre-Awards
Samira Chamaa is the Manager of Grants and Pre-Awards with more than 15 years of experience specializing in the health research sector. She is responsible for the direction and overall management of pre-award grant and award administration, and post-award non-financial administration. She provides leadership for incorporating national best practices into institutional policies and procedures to ensure compliance with agency terms and conditions, and Institutional policy. Samira works with scientists, clinical researchers, trainees, administrative and finance teams to support the successful application and administration of research grants. From major competitions to internal grant programs, Samira advises and assists researchers at all levels of their careers to receive the essential funding that will propel health research forward. Prior to joining the CHEO Research Institute in 2011, Samira worked at the University of Ottawa and the Ottawa Heart Institute supporting basic science, translational, clinical and industry sponsored research projects, contracts and educational programs.
Manager, Contracts Office
Megan Radmore is an in-house lawyer (J.D.) and Manager of the CHEO Research Institute’s Contracts Office. Previously, Megan built a regulatory, advertising and commercial law practice in the health and food sectors at a top-tier, international law firm, Gowling WLG (Canada) LLP. In recent years, she has lectured at the University of Ottawa’s Faculty of Law, and authored and contributed to a number of publications. She has also worked in corporate law, and spent a year advising Ottawa’s entrepreneurs and innovation community. In her academic studies, Megan conducted extensive research on the intersections between global trade, intellectual property and access to medicines, and participated in Open AIR, a global, collaborative research network that uncovers insights about access to knowledge. She was also the recipient of a Social Justice Fellowship, and conducted human rights advocacy for a term in Phnom Penh, Cambodia. At CHEO Research Institute, Megan’s team of lawyers/contracts specialists support research by drafting, negotiating, reviewing and managing all legal agreements between the Institute, and its governmental, institutional and industry partners. When Megan isn’t hard at work, she is a proud parent supporter of CHEO, as a busy mom/wife to a young family.
Manager, Quality Assurance & Regulatory Compliance
Sabrina has 19 years clinical research experience with more than half of her experience in regulated clinical trials. Sabrina joined the CHEO RI team in 2016 as part of the Quality Assurance and Regulatory Compliance Program. Sabrina has vast knowledge in the areas of quality assurance, clinical trial management, Good Clinical Practice, Health Canada and FDA regulations, and other international best practice guidelines. Sabrina aims to provide the best support and service to the research community, and works collaboratively with various departments to navigate the complex and ever changing regulatory environment.
The Annual Report 2020
Click here to view the 2020 CHEO Research Institute Annual Report – Nimble.
The Annual Report for 2019
Past annual reports are available upon request. Please email Michelina Sicoli at [email protected]